alliReport

Free! Join

Discussions
Your INDEPENDENT source of news about the new diet drug alli (low-dose Xenical)
 
alli News from March 2007 -- News About Low-Dose Xenical
 
Diet Pill alli Begins Recruiting 400 Would-Be Dieters for Prelaunch Test
 

Diet pill alli (low-dose Xenical) has begun recruiting 400 would-be dieters for a prelaunch test of educational program being designed to support the first FDA-approved over-the-counter diet drug.

Several readers of alliReport.com report they have received emails inviting them to apply to become part of something called the alli First Team Community, which is built around a password-protected online forum.

"As a member of the alli First Team community, you will be provided with the only FDA-approved weight loss product (alli capsules), educational materials and tools to help you on your journey, and an on-line community to support your efforts," the email said.

"If you are selected to join this community, we ask that you read the materials that we’ll send you to help you get ready, take alli with each meal containing fat, keep a daily food journal, log in to the community and contribute your thoughts (via surveys, bulletin boards, chats, etc.) at least once a week.

"You can expect to spend 10-15 minutes online per week. In addition to sharing tips and building friendships with other members, you will receive a free supply of alli for 6 months," the email added.

GlaxoSmithKline said it would send participants the first 3-month supply of the diet pill prior to its being available in stores, suggesting -- since next week is April -- that alli will not be generally available until at least July.

The email also indicated that participants in the trial who follow the alli program and are successfully losing weight may also be asked to become part of the alli public relations program and speak to members of the media about their experiences.

If you are selected for the alli First Team community, please keep the alliReport.com posted on your experiences.

 
 
 
 
 

 

Other Diet Resources
Privacy Policy | Terms and Disclaimers | About the alli Report
Click to VerifyWe subscribe to the HONcode principles of the HON Foundation.
This is an independent news site reporting on alli, a half-strength version of the diet drug Xenical (orlistat), which GlaxoSmithKlein hopes to market under the trademarked name alli. Nothing on this site is intended to infringe on that trademark. Nothing on this site is intended as medical advice. The information provided is for informational purposes only. Always consult a doctor or medical professional with questions regarding a medical condition.

Last Updated: 03/24/2007 Copyright 2004-2006 Medical Week News, Inc. All Rights Reserved